Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12609000266268
ACTRN12609000266268
Completed
未知

Initiating Dialysis Early and Late (IDEAL) Study. A study reviewing the effect of the timing of dialysis initiation on survival in subjects with chronic kidney disease.

Steering Committee of the IDEAL Study0 sites800 target enrollmentMay 14, 2009
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsChronic Kidney diseaseCardiac diseaseNutritionRenal and Urogenital - Kidney disease

Overview

Phase
未知
Intervention
Not specified
Conditions
Chronic Kidney disease
Sponsor
Steering Committee of the IDEAL Study
Enrollment
800
Status
Completed
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 14, 2009
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Steering Committee of the IDEAL Study

Eligibility Criteria

Inclusion Criteria

  • •Age greater than 18 years. Progressive chronic kidney disease. GFR between 10\-20ml/min/1\.73m^2\.

Exclusion Criteria

  • •Significant cancer. Planned live renal transplant in the next 12 months.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Trial for the initiation of dialysis patients by EPA for prevention of cardiovascular event in Juntendo University Hospital
JPRN-UMIN000012150Department of Internal Medicine,Juntendo University Faculty of Medicine200
Active, not recruiting
Not Applicable
A Study in Renal Predialysis and Dialysis Patients of the Safety, Tolerability, and Immunogenicity of Recombinant Hepatitis B Vaccine Manufactured With a Modified Process - NDProphylactic vaccination against infection with hepatitis B virus in renal predialysis and dialysis patientsMedDRA version: 9.1Level: LLTClassification code 10038474Term: Renal insufficiency
EUCTR2006-003650-20-ITMerck and Co Inc.276
Active, not recruiting
Phase 1
A Study in Renal Predialysis and Dialysis Patients of the Safety,Tolerability, and Immunogenicity of Recombinant Hepatitis BVaccine Manufactured with a Modified Process - Hepatitis B Vaccine (Recombinant) Dialysis StudyHepatitis BMedDRA version: 8.1Level: LLTClassification code 10019731Term: Hepatitis B
EUCTR2006-003650-20-GBMerck & Co Inc.,276
Unknown
Not Applicable
Assessment of Dialysis Initiation by a Fuzzy Mathematics EquationChronic Kidney Disease
NCT03385902The First Affiliated Hospital of Dalian Medical University388
Completed
Not Applicable
The Effects of Dialysis dose at the Initiation of Treatment on Peritoneal Dialysis
JPRN-UMIN000018433Department of Internal Medicine, St. Marianna University School of Medicine, Division of Nephrology and Hypertension80